Post Profile

First Large Clinical Trial of Flu Vaccines Designed to Prevent Heart and Lung-Related Illness Begins

Heart disease patients enrolled in a clinical trial - designed to test whether a stronger dose of the influenza vaccine can prevent death or hospitalization due to a heart attack, heart failure, stroke or pneumonia - have begun receiving their first flu shots in Toronto and Boston.
read more


Related Posts

Patients with HIV May Benefit from Quadruple the Standard Dose of Seasonal Flu Vaccine

Academics / General Science : Science Codex

Administering a quadruple dose of seasonal flu vaccine may help better protect HIV-infected patients from serious illness or death from influenza. In a randomized, double-blind, controlled trial, 190 HIV-positive adults were randoml...

Intercell Starts A Phase I Clinical Trial For A New Streptococcus Pneumoniae Vaccine

Health : Medical News Today

Intercell AG (VSE: ICLL) announced that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started. Intercell's vaccine candidate is a recombina...

Flu Vaccine Associated With Lower Risk of Cardiovascular Events

Health : Newswise Medical News

Receiving an influenza vaccination was associated with a lower risk of major adverse cardiovascular events such as heart failure or hospitalization for heart attack, with the greatest treatment effect seen among patients with recent...

Geriatrician Leads National Study to Determine if Higher Dose Flu Vaccine Is More Effective for Nursing Home Residents

Health : Newswise Medical News

This research is evaluating whether a higher dose of flu vaccine reduces hospitalizations and deaths compared with a standard dose of vaccine. Nearly 800 nursing homes have be enrolled and randomized in the national study.

First trial of vaccine to treat Parkinson's disease begins

Health : LA Times: Health

The Austrian company AFFiRiS A.G. of Vienna said this week it has begun the first-ever clinical trials of a vaccine to treat Parkinson's disease. The study of as many as 32 patients is designed to test the safety and tolerability of...


Copyright © 2016 Regator, LLC